Generare
Chemical Manufacturing · Synthetic Biology
1open role
$23.2Mlatest round · Venture round · Apr 2026 · 7 mo ago
2backers · Alven, Daphni
10+team · employees, estimated range
Overview
Generare explores microbial chemistry to build a library of nature-evolved molecules for discovery. Meet our team, explore careers and stay in touch.
Key facts
As of Nov 13, 2026, Alion lists 1 open role at Generare. Generare is headquartered in Paris, France. The latest round is Venture - Series Unknown of $23.2M, announced in 2026.
- Open roles
- 1Job postings Alion tracks, as of Nov 13, 2026
- Headquarters
- Paris, FranceAlion company profile, updated Nov 13, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $23.2MSum of 1 equity round Alion knows
- Latest round
- Venture - Series Unknown · $23.2M · Apr 2, 2026Press report · siliconangle.com
Funding and backers
Total raised
$23.2M
1 round on record
Latest round
$23.2M
Venture round · Apr 2026 · 7 mo ago
Team
11-50
employees, estimated range
Hiring now
2
open roles
Backers
2
Alven, Daphni
The money's age
Fresh money
7 months since the last round · hiring slowed
Momentum
20/100
fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 2
Raised a round Venture round $23.2M · SiliconANGLE
Jul 2023
Website went live first capture in the Wayback Machine
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2026 | $23.2M | — | SiliconANGLE |
Backed byfrom the funds' portfolios and accelerator catalogs
Alven 
Daphni Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
StrainX Bioworks is a next-generation synthetic biology company engineering microbial strains and precision fermentation to produce…
Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the…
Visolis engineers a new industrial standard with biology and chemistry, creating fuels and chemicals that are safer, perform better, and…
Meet the Mafer AI team: engineers and scientists building the AI data platform for R&D in formulation industries. We.
Ever Dye is a French chemistry company that produces naturally made dyes that reduce carbon emissions and protect water. Its job ad seeks a…
Provectus Algae is a biosolutions discovery and development platform. We mine a photosynthetic microbe library that has never been mined…
Jobs
No jobs available at this time.
Growth
Hiring Momentum
25/100
Slowing
Open positions
1
0 opened / 1 closed in 30 days
Median time-to-fill
45 days
faster than 30% of the market
ATS activity
Every ~6 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
17% ▼
Communications
17% ▼
Management
17% ▼
Sales
17% ▼
Science & Research
17% ▼
Early Careers
17% ▲
Financials
Total raised
$23.2M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $23.2M | Details |
Tech stack
Technologies named in job postings at Generare over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
85/100
Frameworks & libraries
PennyLane
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Generare获2320万美元融资用AI发现未知分子推进药物开发_腾讯新闻
总部位于巴黎的生物技术公司Generare Bioscience宣布完成2000万欧元约2330万美元的早期融资由Alven和Daphni共同领投所有现有投资者包括Galion.exe、T....
Read more
Report
Generare raises €20 million to enhance drug discovery compound library
Generare raises €20 million to enhance drug discovery compound library
Read more
Report
Generare: €20 Million Raised For Techbio Platform Unlocking Novel Drug Molecules
Paris-based techbio company Generare has raised €20 million in a Series A funding round co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners. Founded in 2023, the company is focu
Read more
Report
Generare raises $23.2M to discover unknown molecules and advance new drugs
Generare raises $23.2M to discover unknown molecules and advance new drugs - SiliconANGLE
Read more
Report
Generare.bio lève 5 millions d'euros pour découvrir des médicaments grâce à l'ADN microbien
La biotech parisienne Generare.bio annonce avoir levé 5 millions d'euros pour accélérer le développement de sa plateforme de biosynthèse et de clonage,
Read more
Report
Frenchbiotech Generare speeds up hunt for new drugs by cloning natural molecules
French biotech startup Generare has closed a €5 million seed round (around $5.5 million at current exchange rates) to step up development of what it touts as a highly scalable approach to identifying promising compounds for drug discovery that already exi
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Paris
Paris
France
HQ
1 open roles 6 posted in 90 days 10-50 est. staff
hires for Sales
How to cite this page
Alion, "Generare: key facts", as of Nov 13, 2026. https://alion.io/company/generare
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0